Piperazine → HCID 14651175, compound
Reaction equation
[Cl:1][C:2]1[C:3](F)=[C:4]([F:20])[C:5]([CH3:19])=[C:6]2[C:11]=1[N:10]([CH:12]1[CH2:14][CH2:13]1)[CH:9]=[C:8]([C:15]([OH:17])=[O:16])[C:7]2=[O:18].[NH:22]1[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]1>C(#N)C>[Cl:1][C:2]1[C:3]([N:22]2[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]2)=[C:4]([F:20])[C:5]([CH3:19])=[C:6]2[C:11]=1[N:10]([CH:12]1[CH2:14][CH2:13]1)[CH:9]=[C:8]([C:15]([OH:17])=[O:16])[C:7]2=[O:18]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A suspension of 0.38 g (1.21 mmol) of 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid, 0.42 g (4.88 mmol) of piperazine and 20 ml of acetonitrile was refluxed for four hours, then stirred at room temperature overnight. The precipitate was filtered and washed with water and acetonitrile to give 0.32 g of the title compound, mp 234°-235° C.
Workup
- temperaturewas refluxed for four hours
- filtrationThe precipitate was filtered
- washwashed with water and acetonitrile
Sources & evidence
- ORD record
- ord-5459659c052448e9a652ff212ed158ca
- Source dataset
- uspto-grants-1990_04
- Patent number
- US04920120
Reaction notes
Loading…